If the two sides do reach an agreement, the titanic transaction could be among the biggest in Boston Scientific's history.

The commercial software also reduced the median detection and notification time for incidental PE in flagged scans from “several days” down to just 1 hour.

Cardiovascular Associates of America and Novocardia have joined forces to form what they describe as the "strongest cardiovascular network in America."

HFpEF now accounts for a majority of heart failure cases, highlighting the importance of ensuring both primary care providers and dedicated heart teams know as much about this topic as possible. 

Patients with severe COVID-19 cases that required ventilation were 16 times more likely to develop ventricular tachycardia within six months, researchers found. 

After high-risk medical devices go through the initial FDA approval process, it is relatively easy for manufacturers to get updates to those devices approved. New evidence suggests that this policy could be leading to more recalls, especially among cardiovascular devices.  

HeartPlace, a Dallas-based cardiology practice with more than 20 locations, is the newest member of the USHV family. 

Researchers evaluated data from more than 200 patients who underwent redo TAVR, noting that women and patients with a higher BMI faced a higher risk of coronary flow compromise.

“These decisions are never easy, and we’re taking great care to treat all impacted employees with dignity and respect," the company told Cardiovascular Business in a statement.

 “This event was life-changing, but it is not the end of my story,” Hamlin said during a press conference.